Maintenance haemodialysis and delayed administration of appropriate antibiotics increase 30-day mortality among patients with non-hospital-acquired meticillin-resistant Staphylococcus aureus bacteraemia

International Journal of Antimicrobial Agents

Volumn 35, Issue 5, 2010, Pages 511-512

  Su, Chi Ting ^a   Hsueh, Po Ren ^a   Wu, Vin Cent ^a   Wang, Cheng Yi ^b   Hu, Fu Chang ^a   Chen, Yung Ming ^a   Tsai, Tun Jun ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; DRUG ADMINISTRATION; DRUG EFFICACY; HEALTH CARE FACILITY; HEMODIALYSIS PATIENT; HOSPITAL; HUMAN; LETTER; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NURSING HOME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TAIWAN; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; KIDNEY FAILURE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949659315     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.12.016     Document Type: Letter

References (6)

1. Ala'Aldeen D. A non-multiresistant community MRSA exposes its genome. Lancet 2002, 359:1791-1792.
2. Faria N.A., Oliveira D.C., Westh H., Monnet D.L., Larsen A.R., Skov R., et al. Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection. J Clin Microbiol 2005, 43:1836-1842.
3. Greiner W., Rasch A., Köhler D., Salzberger B., Fätkenheuer G., Leidig M. Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. Clin Microbiol Infect 2007, 13:264-268.
4. Engemann J.J., Friedman J.Y., Reed S.D., Griffiths R.I., Szczech L.A., Kaye K.S., et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005, 26:534-539.
5. Kollef M.H., Shorr A., Tabak Y.P., Gupta V., Liu L.Z., Johannes R.S. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
6. Schramm G.E., Johnson J.A., Doherty J.A., Micek S.T., Kollef M.H. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 2006, 34:2069-2074.